Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006168 · ClinicalTrials.gov registry record · Phase 3
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00006168 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
The verdict
NCT00006168, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The major thrust is to determine whether treatment of patients with Primary Biliary Cirrhosis (PBC) with Ursodiol (Ursodeoxycholic Acid-UDCA) plus methotrexate (MTX) is more effective than treatment with UDCA alone.
Interventions
- DRUG Methotrexate
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-01 |
| Est. Completion | 2004-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006168
The ClinicalTrials.gov registry entry for NCT00006168 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methotrexate is the first listed.
NCT00006168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006168 about?
NCT00006168 is a clinical study titled "Ursodiol-Methotrexate for Primary Biliary Cirrhosis". The major thrust is to determine whether treatment of patients with Primary Biliary Cirrhosis (PBC) with Ursodiol (Ursodeoxycholic Acid-UDCA) plus methotrexate (MTX) is more effective than treatment with UDCA alone.
What is the current status of trial NCT00006168?
This trial is currently completed. It is a Phase 3 study. The study started on 1994-01. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00006168?
The interventions under investigation include: Methotrexate (DRUG).
Who is sponsoring clinical trial NCT00006168?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.